Cases & Deals

  • Home
  • Practices
  • BioCircuit Technologies to be acquired by Axogen

Share

BioCircuit Technologies to be acquired by Axogen

September 2026

Client(s) BioCircuit Technologies, Inc.

Jones Day is advising BioCircuit Technologies in the $200 million acquisition by Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.